Douglas J. Robertson, MD, MPH
Title(s):
Professor of Medicine
Professor of The Dartmouth Institute
Department(s):
Medicine
The Dartmouth Institute
Education:
Georgetown University, BS 1988
U. Connecticut School of Medicine, MD 1992
University of North Carolina, MPH 2000
Programs:
The Dartmouth Institute for Health Policy and Clinical Practice
Websites:
http:
Contact Information:
VA Medical Center
215 N Main St
Mail Code 111E
White River Junction VT 05009
Office: 802 295 9363
Phone: x5590
Professional Interests:
Colorectal Cancer Epidemiology and Outcomes
Pharmacoepidemiology of GI disease
Grant Information:
1.Prospective Evaluation of Risk Factors for Large (≥ 1cm) Colonic Adenomas in Asymptomatic Subjects. A large multicenter trial funded by the VA Cooperative Studies Program. Principal Investigator: David Lieberman. (Role: Site PI)
2.Translation of Colorectal Cancer Screening Guidelines to Practice-A System Intervention. A multicenter trial funded by the VA Colorectal Cancer Queri. Principal Investigator: Linda Humphrey. (Role Site PI)
3.Colorectal Chemoprevention with Calcium and Vitamin D. A large randomized placebo controlled trial funded by the National Institutes of Health. Principal Investigator: John Baron (Role Clinical Director)
4.Developing Sensible Screening Strategies Following Colonoscopy. VA Health Services Research & Development Career Development Award (Principal Investigator)
Courses Taught:
Scientific Basis of Medicine-GI Section
Selected Publications: |
|
Baseline Colonoscopy Findings Associated with 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance. Overuse of Cystoscopic Surveillance Among Patients With Low-risk Non-Muscle-invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Factors. The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer. No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial. Metachronous Neoplasias Arise in a Higher Proportion of Colon Segments From Which Large Polyps Were Previously Removed, and Can be Used to Estimate Incomplete Resection of 10-20 mm Colorectal Polyps. Opportunities and Challenges in Moving From Current Guidelines to Personalized Colorectal Cancer Screening. Extent of Risk-Aligned Surveillance for Cancer Recurrence Among Patients With Early-Stage Bladder Cancer. Learning to be More Positive About FIT. Body mass index, calcium supplementation and risk of colorectal adenomas. Monitoring compliance with colorectal cancer screening: Do we have it covered? |
|
